Early exposure to thimerosal-containing vaccines and children’s cognitive development. A 9-year prospective birth cohort study in Poland

European Journal of Pediatrics

Volumn 174, Issue 3, 2015, Pages 383-391

  Mrozek Budzyn, Dorota ^a   Majewska, Renata ^a   Kiełtyka, Agnieszka ^a  

^a JAGIELLONIAN UNIVERSITY MEDICAL COLLEGE   (Poland)

Author keywords

Children; Developmental outcomes; Ethylmercury; Vaccines

Indexed keywords

DIPHTHERIA PERTUSSIS TETANUS VACCINE; HEPATITIS B VACCINE; RECOMBINANT HEPATITIS B VACCINE; THIOMERSAL; PRESERVATIVE; VACCINE;

ADULT; ARTICLE; ASSESSMENT OF HUMANS; BAYLEY SCALES OF INFANT DEVELOPMENT; CHILD DEVELOPMENT; COGNITIVE DEVELOPMENT; COHORT ANALYSIS; DIPHTHERIA; DRUG FORMULATION; ENVIRONMENTAL MONITORING; FAGAN TEST OF INFANT INTELLIGENCE; FEMALE; HEPATITIS B; HUMAN; MALE; NEWBORN PERIOD; PERINATAL DRUG EXPOSURE; PERTUSSIS; POLAND; PRIORITY JOURNAL; PROSPECTIVE STUDY; PSYCHOLOGIC TEST; TETANUS; UMBILICAL CORD BLOOD; VACCINATION; WECHSLER INTELLIGENCE SCALE; CHEMISTRY; CHILD; COGNITION; DRUG EFFECTS; INFANT; INTELLIGENCE TEST; NEWBORN; PRESCHOOL CHILD;

CHILD; CHILD DEVELOPMENT; CHILD, PRESCHOOL; COGNITION; DIPHTHERIA-TETANUS-PERTUSSIS VACCINE; FEMALE; HEPATITIS B VACCINES; HUMANS; INFANT; INFANT, NEWBORN; INTELLIGENCE TESTS; MALE; POLAND; PRESERVATIVES, PHARMACEUTICAL; PROSPECTIVE STUDIES; THIMEROSAL; VACCINES;

EID: 84923333236     PISSN: 03406199     EISSN: 14321076     Source Type: Journal    
DOI: 10.1007/s00431-014-2412-5     Document Type: Article

References (21)

1. Andrews N, Miller E, Grant A, Stowe J, Osborne V, Taylor B (2004) Thimerosal exposure in infants and developmental disorders: a retrospective cohort study in the United Kingdom does not support a causal association. Pediatrics 114(3):584–591
2. Bayley N (1993) Manual for the Bayley Scales of Infant Development, 2nd edn. The Psychological Corporation, San Antonio
3. CDC (2003) Whole blood lead, cadmium and mercury determined using inductively coupled plasma mass spectrometry, DLS method code: 2003-01/OD. CLIA methods. Centers for Disease Control and Prevention, Atlanta, GA
4. Centers for Disease Control and Prevention (2004) Recommended childhood and adolescent immunization schedule—United States, 2004 Jan-Jun [online]. Available from URL: http://www.cdc.gov/mmwr/preview/mmwrhtml/mm5301-Immunizationa1.htm [Accessed 2004 Jan 12]
5. Ekstrand J, Nielsen JB, Havarinasab S, Zalups RK, Söderkvist P, Hultman P (2010) Mercury toxicokinetics—dependency on strain and gender. Toxicol Appl Pharmacol 243(3):283–291
6. Grandjean P, Satoh H, Murata K, Eto K (2010) Adverse effects of methylmercury: environmental health research implications. Environ Health Perspect 118(8):1137–1145
7. Grandjean P, Weihe P, White RF, Debes F, Araki S, Yokoyama K, Murata K, Sørensen N, Dahl R, Jørgensen PJ (1997) Cognitive deficit in 7-year-old children with prenatal exposure to methylmercury. Neurotoxicol Teratol 19(6):417–428
8. Heron J, Golding J, ALSPAC Study Team (2004) Thimerosal exposure in infants and developmental disorders: a prospective cohort study in the United Kingdom does not support a causal association. Pediatrics 114(3):577–583
9. Jedrychowski W, Jankowski J, Flak E, Skarupa A, Mroz E, Sochacka-Tatara E, Lisowska-Miszczyk I, Szpanowska-Wohn A, Rauh V, Skolicki Z, Kaim I, Perera F (2006) Effects of prenatal exposure to mercury on cognitive and psychomotor function in one-year-old infants: epidemiologic cohort study in Poland. Ann Epidemiol 16(6):439–447
10. Jedrychowski W, Perera FP, Jankowski J, Mrozek-Budzyn D, Mroz E, Flak E, Edwards S, Skarupa A, Lisowska-Miszczyk I (2009) Very low prenatal exposure to lead and mental development of children in infancy and early childhood: Krakow prospective cohort study. Neuroepidemiology 32(4):270–278
11. Joint Statement issued by the AAP and the PHS in July 1999 “established the goal of removing the vaccine preservative thimerosal as soon as possible from vaccines routinely recommended for infants.” from http://www.vaccinesafety.edu/AAFP-AAP-ACIP-thimerosal.htm [accessed 2012 Jan 12]
12. Kelly YJ, Watt RG, Nazroo JY (2006) Racial/ethnic differences in breastfeeding initiation and continuation in the United Kingdom and comparison with findings in the United States. Pediatrics 118(5):e1428–e1435
13. Lederman SA, Jones RL, Caldwell KL, Rauh V, Sheets SE, Tang D, Viswanathan S, Becker M, Stein JL, Wang RY, Perera FP (2008) Relation between cord blood mercury levels and early child development in a World Trade Center cohort. Environ Health Perspect 116(8):1085–1091
14. Marques RC, Dórea JG, Bernardi JV, Bastos WR, Malm O (2009) Pre- and post-natal mercury exposure, breastfeeding and neurodevelopment during the first five years. Cogn Behav Neurol 22:134–141
15. Marques RC, Dórea JG, Bernardi JV (2010) Thimerosal exposure (from tetanus-diphtheria vaccine) during pregnancy and neurodevelopment of breastfed infants at 6 months. Acta Paediatr 99(6):934–939
16. Myers GJ, Davidson PW, Cox C, Shamlaye C, Cernichiari E, Clarkson TW (2000) Twenty-seven years studying the human neurotoxicity of methylmercury exposure. Environ Res 83(3):275–285
17. Oken E, Radesky JS, Wright RO, Bellinger DC, Amarasiriwardena CJ, Kleinman KP, Hu H, Gillman MW (2008) Maternal fish intake during pregnancy, blood mercury levels, and child cognition at age 3 years in a US cohort. Am J Epidemiol 167(10):1171–1181
18. Pichichero ME, Cernichiari E, Lopreiato J, Treanor J (2002) Mercury concentrations and metabolism in infants receiving vaccines containing thiomersal: a descriptive study. Lancet 360(9347):1737–1741
19. Pichichero ME, Gentile A, Giglio N, Umido V, Clarkson T, Cernichiari E, Zareba G, Gotelli C, Gotelli M, Yan L, Treanor J (2008) Mercury levels in newborns and infants after receipt of thimerosal-containing vaccines. Pediatrics 121(2):e208–e214
20. The European Agency for the Evaluation of Medicinal Products, Committee for Proprietary Medicinal Products. Points to consider on the reduction, elimination or substitution of thimerosal in vaccines: 2001 Apr 26; EMEA/CPMB/BWP2517/00 [on-line]. Available from URL: http://www.tga.gov.au/pdf/euguide/bwp251700en.pdf [Accessed 2004 Jan 12]
21. Thompson WW, Price C, Goodson B, Shay DK, Benson P, Hinrichsen VL, Lewis E, Eriksen E, Ray P, Marcy SM, Dunn J, Jackson LA, Lieu TA, Black S, Stewart G, Weintraub ES, Davis RL, DeStefano F, Team VSD (2007) Early thimerosal exposure and neuropsychological outcomes at 7 to 10 years. N Engl J Med 357(13):1281–1292